title: Does the risk of lymphoma in patients with RA treated with TNF inhibitors differ according to the histological subtype and the type of TNF inhibitor?
authors.affiliation: Hôpitaux Universitaires Paris Sud, Assistance Publique-Hôpitaux de Paris, Le Kremlin Bicêtre, France.
authors.forename: Gaetane
authors.initials: G
authors.lastname: Nocturne
authors.affiliation: Department of Rheumatology, AP-HP, Hôpital Bicêtre, Le Kremlin Bicêtre, France.
authors.forename: Raphaele
authors.initials: R
authors.lastname: Seror
authors.affiliation: Hôpitaux Universitaires Paris Sud, Assistance Publique-Hôpitaux de Paris, Le Kremlin Bicêtre, France.
authors.forename: Xavier
authors.initials: X
authors.lastname: Mariette
mesh_terms: D018501:Antirheumatic Agents; D001172:Arthritis, Rheumatoid; D001688:Biological Products; D006801:Humans; D008223:Lymphoma; D012219:Rheumatology
chemical_list: D018501:Antirheumatic Agents; D001688:Biological Products
keywords: Disease Activity; Rheumatoid Arthritis; Treatment